Randomised controlled trial into the role of ramipril in fibrosis reduction in rheumatic heart disease: the RamiRHeD trial protocol

INTRODUCTION: Rheumatic heart disease (RHD) is a major burden in developing countries and accounts for 80% of all people living with the disease, where it causes most cardiovascular morbidity and mortality in children and young adults. Chronic inflammation and fibrosis of heart valve tissue due to c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ambari, Ade Meidian, Setianto, Budhi, Santoso, Anwar, Radi, Basuni, Dwiputra, Bambang, Susilowati, Eliana, Tulrahmi, Fadilla, Wind, Annemiek, Cramer, Maarten Jan Maria, Doevendans, Pieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438922/
https://www.ncbi.nlm.nih.gov/pubmed/34518254
http://dx.doi.org/10.1136/bmjopen-2020-048016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438922/
https://www.ncbi.nlm.nih.gov/pubmed/34518254
http://dx.doi.org/10.1136/bmjopen-2020-048016

Ejemplares similares